Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

703 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Regulation For Rigorous Clinical Investigation Of Medical Devices: The Missing Link Of The Atma-nirbhar Drive In Healthcare

    India aims to be the pharmacy of the world. To achieve this dream, it is important that drugs and medical devices "made-in-India" are trusted by regulators and users globally.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Ikigai Law
    Ikigai Law
  • Article

    Reassessing India's Medical Device Recall Framework: Regulatory Gaps And The Case For Reform

    The global medical device industry is undergoing remarkable expansion, driven by technological innovation, rising healthcare demands, and increased investment across markets.
    IndiaFood, Drugs, Healthcare, Life Sciences
Luthra and Luthra Law Offices India
Luthra and Luthra Law Offices India
  • Article

    Specially Processed Foods Under Nutra Regulations: A Guide To Labelling, Display, And Packaging Compliances

    Food for special dietary uses, functional foods, nutraceuticals or health supplements are specifically processed or formulated to meet specific dietary...
    IndiaFood, Drugs, Healthcare, Life Sciences
    Spice Route Legal
    Spice Route Legal
  • Article

    The Oxytocin Ban Story

    Oxytocin is life-saving drug that is used for the induction and assistance of labour in women during childbirth
    IndiaFood, Drugs, Healthcare, Life Sciences
    Cyril Amarchand Mangaldas
    Cyril Amarchand Mangaldas
  • Article

    Streamlining Cost Data Visibility To Enhance Strategic Decision-making

    The client, a global leader in consumer healthcare, had recently transitioned into an independent organization.
    IndiaGovernment, Public Sector
    Nexdigm Private Limited
    Nexdigm Private Limited
  • Article

    When The File Moved On, The Order Stood Still: The Delhi High Court Remands Medilabo On Section 3(i)

    The Delhi High Court in Medilabo RFP Inc. v. Controller of Patents[1] set aside a refusal under Section 3(i) of the Patents Act, 1970 concerning a pharmaceutical invention for neurodegenerative diseases, The Court’s intervention turned on a more fundamental principle of patent adjudication: the Controller must decide an application on the basis of the claims as they stand on the date of the order and must deal with every objection raised in the hearing notice through reasoned findings.
    IndiaIntellectual Property
    S.S. Rana & Co.
    S.S. Rana & Co.
  • Article

    Forensic Analytics In Pharmaceutical Fraud Investigations: Lessons From Recent Cases

    The pharmaceutical industry faces escalating risks from sophisticated fraud schemes, including counterfeit drug distribution, billing irregularities...
    IndiaFood, Drugs, Healthcare, Life Sciences
    Ankura Consulting Group LLC
    Ankura Consulting Group LLC
  • Article

    Global Overview Of Pharma Ethical Marketing Code

    For quite some time, the government of India has been upholding that it was drafting a mandatory code on ethical marketing of pharmaceuticals with penal provisions since the UCPMP...
    IndiaFood, Drugs, Healthcare, Life Sciences
    King, Stubb & Kasiva
    King, Stubb & Kasiva
  • Article

    Health Ministry Annual Updates On National Health Missions/Programs For Year 2017

    Year 2017 was the year of health survey and regulatory reforms, as many survey reports were published in various areas of health such as – reports on Universal Health Coverage (UHC); Global Hunger Index (GHI); ...
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    E-Pharmacies: The Story So Far & The Way Forward

    A petition seeking de-linking of a website, namely www.aarogyasetumitr.in, from the Aarogya Setu application, has been filed before the Delhi High Court.[1] It is contended that the linking...
    IndiaFood, Drugs, Healthcare, Life Sciences
    Luthra and Luthra Law Offices India
    Luthra and Luthra Law Offices India
  • Article

    Healthcare Data Across Borders: Reconciling India’s DPDP Framework With The GDPR

    An analysis of cross-border healthcare-data transfers under India’s Digital Personal Data Protection framework and the GDPR, examining consent, sensitive health information, processor obligations, transfer safeguards, localisation and regulatory risk.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    The Rise Of Sound-Alike Pharmaceutical Trademarks: A Public Health Crisis?

    A physician prescribes Olvance, an antihypertensive with Olmesartan, whiles the pharmacist, distracted and in a hurry, pulls Oleanz, an antipsychotic with Olanzapine. The two names share similar opening and internal letter patterns.
    IndiaIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    Look A-Like Sound A-Like (LASA) Drugs: A Multifaceted Challenge

    "Look a-like, sound a-like" (LASA) refers to a significant issue within the pharmaceutical industry where medications bear similar names or appearances...
    IndiaFood, Drugs, Healthcare, Life Sciences
    K Singhania & Co
    K Singhania & Co
  • Article

    COVID-19| Updates - Measures By Various State Governments

    The delivery and administration of health care largely rests with individual states in India as health care is a state subject.
    IndiaFood, Drugs, Healthcare, Life Sciences
    CMS INDUSLAW
    CMS INDUSLAW
  • Article

    Health Ministry's Ambitious National Strategic Plan (NSP) 2017-25 For Elimination Of Tuberculosis

    The programme was initiated in 1997 and was expanded to cover the entire country in 2006.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Our Comments To The National Health Authority's Consultation Papers On The Health Facilities Registry, And Healthcare Professionals' Registry

    The post is an overview of our comments to the National Health Authority's consultation papers on two building blocks of the National Digital Health Mission, namely the health facility registry and the healthcare professionals' registry.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Ikigai Law
    Ikigai Law
  • Article

    A Changing Regime - India´s Tryst with January 1, 2005

    The patent regime in India is due for a seismic change on January 1, 2005. When India became a member of WTO and a signatory to TRIPS with effect from January 1, 1995 it was given five years as a developing country, to change its laws to comply with TRIPS. This period was later extended by five years and now comes to end on January 1, 2005.
    IndiaStrategy
    Rajinder Narain & Co
    Rajinder Narain & Co
  • Article

    Budget Wishlist 2021

    After the pandemic ravaged the globe in 2020, the economy plummeted as global businesses suffered due to gaps in the supply chain and social distancing norms that suspended trade...
    IndiaFinance and Banking
    Nexdigm Private Limited
    Nexdigm Private Limited
  • Article

    Checking The Pulse – Recent Legal Developments In The Indian Healthcare And Pharma Sector

    Over the past two months, significant strides have been made in reforming marketing practices within the pharmaceutical industry, alongside efforts to establish fair pricing frameworks for both drugs and medical devices.
    IndiaFood, Drugs, Healthcare, Life Sciences
    CMS INDUSLAW
    CMS INDUSLAW
  • Article

    Healthcare And Pharmaceutical Law Newsletter

    The Healthcare industry in India comprises of hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment.
    IndiaFood, Drugs, Healthcare, Life Sciences
    DLS Law Offices
    DLS Law Offices
  • Showing 601–620 of 703 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics